Position in TEVA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$504,812
-$173,761 QoQ
Shares Held
14,900
-33.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#392
of 671 holders
Holding Since
Mar 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Marex Group plc holds $79,745,220 across 11 Drug Manufacturers - Specialty & Generic names. TEVA ranks #7 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
973,771 | $33,760,640 | |
| 2 | TRLV |
Trulieve Cannabis Corp.
|
3,250,000 | $31,947,500 | |
| 3 | GLAS |
Glass House Brands Inc.
|
750,000 | $9,750,000 | |
| 4 | ZTS |
Zoetis Inc.
|
16,395 | $1,178,144 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
1,351 | $732,012 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
27,000 | $664,470 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
14,900 | $504,812 | |
| 8 | VTRS |
Viatris Inc
|
30,931 | $491,184 |
All Filings in TEVA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $504,812 | 14,900 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $678,573 | 22,529 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $812,926 | 26,047 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $633,330 | 31,353 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $463,497 | 27,655 | Shares | Defined | 2025-08-19 | |
| 2025-03-31 | $361,195 | 23,500 | Shares | Defined | 2026-04-02 | |
| 2023-06-30 | $2,030,735 | 269,686 | Shares | Defined | 2026-04-02 | |
| 2023-03-31 | $1,027,706 | 116,125 | Shares | Defined | 2026-04-02 | |
| No filing history on record for this holder in this stock. | ||||||